Eating Disorder Clinics in the US: Market Size, Businesses & Forecast 2026

The eating disorder clinics industry in the United States comprises specialized facilities providing residential, partial hospitalization, and intensive outpatient care for individuals struggling with conditions such as anorexia nervosa, bulimia nervosa, and binge-eating disorder. The sector has experienced sustained demand due to growing public awareness, broader insurance mandates, and rising clinical diagnoses across diverse demographics. While comprehensive aggregate revenue figures are restricted to private databases, federal initiatives highlight the sector's vital role, including a targeted grant allocation of up to 3.75 million USD in 2026 by the Substance Abuse and Mental Health Ser

Industry snapshot

Key public data points

Historical & forecast

Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.

What does the Eating Disorder Clinics in the US industry cover?

This industry consists of specialized healthcare establishments primarily engaged in providing inpatient, residential, partial hospitalization (PHP), and intensive outpatient (IOP) medical and psychological care for eating disorders. Facilities deploy multidisciplinary teams consisting of physicians, psychotherapists, dietitians, and nursing staff to treat complex behavioral conditions. Treatment models focus on medical stabilization, nutritional rehabilitation, and psychological therapies.

• •Encompasses both residential treatment centers providing 24-hour care and outpatient clinics offering structured daytime therapy.
• •Targets specific clinical conditions classified under the DSM-5, including anorexia nervosa, bulimia nervosa, binge-eating disorder, and ARFID.
• •Excludes general psychiatric hospitals and independent standalone private practices unless they operate as dedicated clinical centers.

Who operates in the industry and how is it structured?

The industry's market structure is highly fragmented, consisting of a mix of regional private-equity-backed institutional chains, non-profit specialized centers, and university-affiliated medical programs. Highly specialized treatment tracks mean that capacity is typically distributed across localized boutique centers rather than massive centralized hospitals. Operators frequently expand through geographical replication or acquiring localized multi-site clinics to gain regional multi-state footprints.

• •Facilities operate under varying institutional models including dedicated behavioral health networks, hospital-affiliated departments, and independent private companies.
• •A large portion of the market relies on commercial private health insurance reimbursements and direct-pay models rather than public Medicaid allocations.
• •Geographic placement is heavily concentrated near major metropolitan areas and affluent regions due to commercial insurance coverage variations.

What drives demand in the industry?

The primary drivers of industry demand are the high lifetime prevalence of eating disorders and expanding healthcare access via public awareness and federal legislation. Federal statistics reveal that a substantial public health burden exists, requiring specialized intervention pathways. The expansion of mental health parity laws has further compelled insurance providers to cover extended residential and partial hospitalization stays.

• •According to SAMHSA data published in 2026, an estimated 1 in 10 people in the United States will experience an eating disorder during their lifetime.
• •SAMHSA estimates that approximately 30 million Americans will struggle with an eating disorder, contributing to severe public health risks.
• •The Mental Health Parity and Addiction Equity Act (MHPAEA) mandates that commercial insurers provide equitable coverage limits for eating disorder treatments relative to medical surgeries.

Who are the notable companies in the industry?

The competitive landscape features dominant private behavioral health networks alongside large diversified public healthcare corporations that manage specialized psychiatric divisions. Because many leading brands are controlled by private equity firms or operate as non-profits, direct public equity listings dedicated solely to eating disorders are limited. Competition is driven by clinical reputation, institutional accreditation, and the breadth of contractual relationships with major managed care organizations.

• •Acadia Healthcare Company, Inc., a prominent publicly traded behavioral health operator, manages dedicated eating disorder programs across its expansive national network.
• •Universal Health Services, Inc. (UHS) represents another major public participant operating specialized behavioral facilities providing acute eating disorder stabilization.
• •The Emily Program and Veritas Collaborative, operating under the Parent company Accanto Health, represent major private institutional providers with multi-state locations.
• •Eating Recovery Center (ERC), backed by major private institutional investors, represents one of the largest dedicated operators offering comprehensive vertical care levels across the country.

What are the recent trends and outlook?

The industry is adapting to modern healthcare delivery through the integration of hybrid virtual-care models and heightened clinical focus on co-occurring conditions. Telehealth platforms emerged rapidly to bridge the structural gap for remote patients who lack regional access to physical residential facilities. Additionally, institutional centers are designing integrated tracks to treat co-occurring substance use disorders alongside primary eating disorders.

• •SAMHSA reports that historical data indicated only 16 percent of surveyed publicly funded substance use disorder programs offered simultaneous eating disorder co-treatment.
• •The emergence of specialized virtual IOP models has broadened provider reach, allowing clinics to capture rural market demand without physical real estate expansion.
• •The rising clinical prevalence of Avoidant/Restrictive Food Intake Disorder (ARFID) has prompted operators to open pediatric-specific treatment wings.

How is the industry regulated?

Facilities operate under strict regulatory oversight dictated by state licensing boards, federal healthcare mandates, and independent medical accreditation bodies. State departments of health control the operational certification required for residential housing and medical stabilization wings. Furthermore, providers must achieve specific independent credentials to maintain formal reimbursement networks with commercial insurers.

• •Facilities must maintain strict compliance with health privacy standards mandated by the Health Insurance Portability and Accountability Act (HIPAA).
• •Clinical operations are independently evaluated and certified by organizations such as The Joint Commission or the Commission on Accreditation of Rehabilitation Facilities (CARF).
• •The federal grant of 3.75 million USD authorized by SAMHSA in 2026 establishes new training and technical standards for practitioners nationwide through the Center of Excellence.

Government, statistical and trade sources used for this Claight analysis.

• Substance Abuse and Mental Health Services Administration (SAMHSA) 2026 ·
• U.S. Census Bureau NAICS Index 2022 ·
• Securities and Exchange Commission (SEC) Public Company Filings